MMP2 and breast carcinoma: To further address a possible role for MMPs in IL-17-dependent invasiveness of breast cancer cell lines, we assayed the supernatants from IL-17-treated and control MDA-MB231 and MDA-MB453 cells for the presence of MMP-2, MMP-3, MMP-9 and TIMP-1.